Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 853 to 858 of 858 entries
Sorted by: Best Match Show Resources per page
[No title available]

Journal of neurophysiology

Dubbioso R, Pellegrino G, Ranieri F, Di Pino G, Capone F, Dileone M, Iodice R, Ruggiero L, Tozza S, Uncini A, Manganelli F, Di Lazzaro V.
PMID: 34936818
J Neurophysiol. 2022 Jan 01;127(1):204-212. doi: 10.1152/jn.00268.2021. Epub 2021 Dec 22.

Preclinical studies have demonstrated that brain-derived neurotrophic factor (BDNF) plays a crucial role in the homeostatic regulation of cortical excitability and excitation/inhibition balance. Using transcranial magnetic stimulation techniques, we investigated whether BDNF polymorphism could influence cortical excitability of the...

Cite
Dubbioso R, Pellegrino G, Ranieri F, et al. . J Neurophysiol. 2021;127(1):204-212doi: 10.1152/jn.00268.2021.
Dubbioso, R., Pellegrino, G., Ranieri, F., Di Pino, G., Capone, F., Dileone, M., Iodice, R., Ruggiero, L., Tozza, S., Uncini, A., Manganelli, F., & Di Lazzaro, V. (2022). . Journal of neurophysiology, 127(1), 204-212. https://doi.org/10.1152/jn.00268.2021
Dubbioso, Raffaele, et al. "." Journal of neurophysiology vol. 127,1 (2022): 204-212. doi: https://doi.org/10.1152/jn.00268.2021
Dubbioso R, Pellegrino G, Ranieri F, Di Pino G, Capone F, Dileone M, Iodice R, Ruggiero L, Tozza S, Uncini A, Manganelli F, Di Lazzaro V. . J Neurophysiol. 2022 Jan 01;127(1):204-212. doi: 10.1152/jn.00268.2021. Epub 2021 Dec 22. PMID: 34936818.
Copy Download .nbib Format: NLM
Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients.

International journal of molecular sciences

Mastrangelo S, Rivetti S, Triarico S, Romano A, Attinà G, Maurizi P, Ruggiero A.
PMID: 34884452
Int J Mol Sci. 2021 Nov 23;22(23). doi: 10.3390/ijms222312648.

Prognosis of metastatic neuroblastoma is very poor. Its treatment includes induction chemotherapy, surgery, high-dose chemotherapy, radiotherapy, and maintenance with retinoic acid, associated with the anti-GD2 monoclonal antibody (ch14.18) dinutuximab. Immunotherapy determined a significant improvement in survival rate and is...

Cite
Mastrangelo S, Rivetti S, Triarico S, et al. Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312648.
Mastrangelo, S., Rivetti, S., Triarico, S., Romano, A., Attinà, G., Maurizi, P., & Ruggiero, A. (2021). Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312648
Mastrangelo, Stefano, et al. "Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312648
Mastrangelo S, Rivetti S, Triarico S, Romano A, Attinà G, Maurizi P, Ruggiero A. Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients. Int J Mol Sci. 2021 Nov 23;22(23). doi: 10.3390/ijms222312648. PMID: 34884452.
Copy Download .nbib Format: NLM
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver.

Cell death & disease

Carotti S, Lettieri-Barbato D, Piemonte F, Ruggiero S, Rosina M, Zalfa F, Zingariello M, Arciprete F, Valentini F, Francesconi M, D'Amico J, De Vincentis A, Baiocchini A, Perrone G, Antonelli-Incalzi R, Morini S, Picardi A, Aquilano K, Vespasiani-Gentilucci U.
PMID: 34795230
Cell Death Dis. 2021 Nov 18;12(12):1092. doi: 10.1038/s41419-021-04382-4.

Recent studies demonstrated reduced blood lysosomal acid lipase (LAL) activity in patients with nonalcoholic fatty liver disease (NAFLD). We aimed to verify hepatic LAL protein content and activity in in vitro and in vivo models of fat overload and...

Cite
Carotti S, Lettieri-Barbato D, Piemonte F, et al. Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver. Cell Death Dis. 2021;12(12):1092doi: 10.1038/s41419-021-04382-4.
Carotti, S., Lettieri-Barbato, D., Piemonte, F., Ruggiero, S., Rosina, M., Zalfa, F., Zingariello, M., Arciprete, F., Valentini, F., Francesconi, M., D'Amico, J., De Vincentis, A., Baiocchini, A., Perrone, G., Antonelli-Incalzi, R., Morini, S., Picardi, A., Aquilano, K., & Vespasiani-Gentilucci, U. (2021). Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver. Cell death & disease, 12(12), 1092. https://doi.org/10.1038/s41419-021-04382-4
Carotti, Simone, et al. "Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver." Cell death & disease vol. 12,12 (2021): 1092. doi: https://doi.org/10.1038/s41419-021-04382-4
Carotti S, Lettieri-Barbato D, Piemonte F, Ruggiero S, Rosina M, Zalfa F, Zingariello M, Arciprete F, Valentini F, Francesconi M, D'Amico J, De Vincentis A, Baiocchini A, Perrone G, Antonelli-Incalzi R, Morini S, Picardi A, Aquilano K, Vespasiani-Gentilucci U. Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver. Cell Death Dis. 2021 Nov 18;12(12):1092. doi: 10.1038/s41419-021-04382-4. PMID: 34795230; PMCID: PMC8602623.
Copy Download .nbib Format: NLM
Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma.

Cancers

Servidei T, Lucchetti D, Navarra P, Sgambato A, Riccardi R, Ruggiero A.
PMID: 34885210
Cancers (Basel). 2021 Dec 03;13(23). doi: 10.3390/cancers13236100.

Intra-tumoral heterogeneity (ITH) is a complex multifaceted phenomenon that posits major challenges for the clinical management of cancer patients. Genetic, epigenetic, and microenvironmental factors are concurrent drivers of diversity among the distinct populations of cancer cells. ITH may also...

Cite
Servidei T, Lucchetti D, Navarra P, et al. Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13236100.
Servidei, T., Lucchetti, D., Navarra, P., Sgambato, A., Riccardi, R., & Ruggiero, A. (2021). Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma. Cancers, 13(23), . https://doi.org/10.3390/cancers13236100
Servidei, Tiziana, et al. "Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13236100
Servidei T, Lucchetti D, Navarra P, Sgambato A, Riccardi R, Ruggiero A. Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma. Cancers (Basel). 2021 Dec 03;13(23). doi: 10.3390/cancers13236100. PMID: 34885210; PMCID: PMC8657076.
Copy Download .nbib Format: NLM
Treatment and outcome of intracranial ependymoma after first relapse in AIEOP 2 nd protocol.

Neuro-oncology

Massimino M, Barretta F, Modena P, Johann P, Ferroli P, Antonelli M, Gandola L, Garrè ML, Bertin D, Mastronuzzi A, Mascarin M, Quaglietta L, Viscardi E, Sardi I, Ruggiero A, Boschetti L, Giagnacovo M, Biassoni V, Schiavello E, Chiapparini L, Erbetta A, Mussano A, Giussani C, Mura RM, Barra S, Scarzello G, Scimone G, Carai A, Giangaspero F, Buttarelli FR.
PMID: 34605902
Neuro Oncol. 2021 Oct 04; doi: 10.1093/neuonc/noab230. Epub 2021 Oct 04.

BACKGROUND: More than 40% of patients with intracranial ependymoma need a salvage treatment within 5 years after diagnosis, and no standard treatment is available as yet. We report the outcome after first relapse of 64 patients treated within the...

Cite
Massimino M, Barretta F, Modena P, et al. Treatment and outcome of intracranial ependymoma after first relapse in AIEOP 2 nd protocol. Neuro Oncol. 2021;doi: 10.1093/neuonc/noab230.
Massimino, M., Barretta, F., Modena, P., Johann, P., Ferroli, P., Antonelli, M., Gandola, L., Garrè, M. L., Bertin, D., Mastronuzzi, A., Mascarin, M., Quaglietta, L., Viscardi, E., Sardi, I., Ruggiero, A., Boschetti, L., Giagnacovo, M., Biassoni, V., Schiavello, E., Chiapparini, L., Erbetta, A., Mussano, A., Giussani, C., Mura, R. M., Barra, S., Scarzello, G., Scimone, G., Carai, A., Giangaspero, F., & Buttarelli, F. R. (2021). Treatment and outcome of intracranial ependymoma after first relapse in AIEOP 2 nd protocol. Neuro-oncology, . https://doi.org/10.1093/neuonc/noab230
Massimino, Maura, et al. "Treatment and outcome of intracranial ependymoma after first relapse in AIEOP 2 nd protocol." Neuro-oncology vol. (2021). doi: https://doi.org/10.1093/neuonc/noab230
Massimino M, Barretta F, Modena P, Johann P, Ferroli P, Antonelli M, Gandola L, Garrè ML, Bertin D, Mastronuzzi A, Mascarin M, Quaglietta L, Viscardi E, Sardi I, Ruggiero A, Boschetti L, Giagnacovo M, Biassoni V, Schiavello E, Chiapparini L, Erbetta A, Mussano A, Giussani C, Mura RM, Barra S, Scarzello G, Scimone G, Carai A, Giangaspero F, Buttarelli FR. Treatment and outcome of intracranial ependymoma after first relapse in AIEOP 2 nd protocol. Neuro Oncol. 2021 Oct 04; doi: 10.1093/neuonc/noab230. Epub 2021 Oct 04. PMID: 34605902.
Copy Download .nbib Format: NLM
Neonatal seizures as onset of Inborn Errors of Metabolism (IEMs): from diagnosis to treatment. A systematic review.

Metabolic brain disease

Falsaperla R, Sciuto L, La Spina L, Sciuto S, Praticò AD, Ruggieri M.
PMID: 34403026
Metab Brain Dis. 2021 Dec;36(8):2195-2203. doi: 10.1007/s11011-021-00798-1. Epub 2021 Aug 17.

Neonatal seizures (NS) occur in the first 28 days of life; they represent an important emergency that requires a rapid diagnostic work-up to start a prompt therapy. The most common causes of NS include: intraventricular haemorrhage, hypoxic-ischemic encephalopathy, hypoglycemia,...

Cite
Falsaperla R, Sciuto L, La Spina L, et al. Neonatal seizures as onset of Inborn Errors of Metabolism (IEMs): from diagnosis to treatment. A systematic review. Metab Brain Dis. 2021;36(8):2195-2203doi: 10.1007/s11011-021-00798-1.
Falsaperla, R., Sciuto, L., La Spina, L., Sciuto, S., Praticò, A. D., & Ruggieri, M. (2021). Neonatal seizures as onset of Inborn Errors of Metabolism (IEMs): from diagnosis to treatment. A systematic review. Metabolic brain disease, 36(8), 2195-2203. https://doi.org/10.1007/s11011-021-00798-1
Falsaperla, Raffaele, et al. "Neonatal seizures as onset of Inborn Errors of Metabolism (IEMs): from diagnosis to treatment. A systematic review." Metabolic brain disease vol. 36,8 (2021): 2195-2203. doi: https://doi.org/10.1007/s11011-021-00798-1
Falsaperla R, Sciuto L, La Spina L, Sciuto S, Praticò AD, Ruggieri M. Neonatal seizures as onset of Inborn Errors of Metabolism (IEMs): from diagnosis to treatment. A systematic review. Metab Brain Dis. 2021 Dec;36(8):2195-2203. doi: 10.1007/s11011-021-00798-1. Epub 2021 Aug 17. PMID: 34403026; PMCID: PMC8580891.
Copy Download .nbib Format: NLM
Showing 853 to 858 of 858 entries